North America's clinical research leader, Centricity Research, announced that Aventiv Research has merged with the organization, extending the reach and capabilities of the largest integrated research site organization across the USA and Canada.

Aventiv Research is the fourth clinical research company to join Centricity Research, which launched in November 2021 when IACT Health and LMC Manna Research joined forces, followed by the merger with True North Clinical Research in December 2021.

With research sites in Ohio and Arizona, Aventiv specializes in phase I-IV pharmaceutical, device, and diagnostic clinical trials in a variety of therapeutic areas. Founded in 2007 by Dr. Samir Arora, a proven leader with over 15 years of experience, Aventiv has conducted 475+ clinical trials with over 55 pharmaceutical sponsors, helping 26 drugs become FDA-approved and available for use.

With this merger, Centricity now offers CROs and sponsors access to 45 clinical research sites, over 1.6 million geographically and ethnically diverse patients, and over 150 experienced investigators who perform trials in more than 35 therapeutic areas, including Infectious Disease, Neurology, Endocrinology, Oncology, Cardiology, Dermatology, Vaccines and more.